Substance misuse and psychiatric comorbidity in adolescents

Current Opinion in Psychiatry

Volumn 18, Issue 4, 2005, Pages 435-439

  Crome, Ilana ^a   Bloor, Roger ^a  

^a KEELE UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Abuse; Adolescent; Dependence; Misuse; Psychiatric disorder; Substance use

Indexed keywords

HALOPERIDOL; METHYLPHENIDATE; NEUROLEPTIC AGENT; OLANZAPINE;

ADDICTION; ALCOHOLISM; ANXIETY DISORDER; ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; CANNABIS ADDICTION; CHILD PSYCHIATRY; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; DEMOGRAPHY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; DRINKING BEHAVIOR; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; FAMILY THERAPY; FOLLOW UP; HIGH RISK POPULATION; HUMAN; MENTAL DISEASE; META ANALYSIS; MOTIVATION; PANIC; PROGNOSIS; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; REVIEW; RISK ASSESSMENT; RISK FACTOR; SCHIZOPHRENIA; SMOKING HABIT; SUBSTANCE ABUSE; SUICIDE; SYSTEMATIC REVIEW;

EID: 20644469044     PISSN: 09517367     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.yco.0000172064.86272.8e     Document Type: Review

References (33)

1. Crame I. Psychiatric comorbidity. In: Crome IB, Ghodse H, Gilvarry E, et al., editors. Young people and substance misuse. London: Gaskell; 2004. pp. 72-84.
2. Henquet C, Krabbendam L, Spauwen J, et al. Prospective cohort study of cannabis use, predisposition for psychosis, and psychotic symptoms in young people. BMJ 2005; 330:11. A well designed prospective study which may have a major effect on the UK legal approach to cannabis.
3. Stefanis NC, Delespaul P, Henquet C, et al. Early adolescent cannabis exposure and positive and negative dimensions of psychosis. Addiction 2004; 99:1333-1341.
4. Boys A, Farrell M, Taylor C, et al. Psychiatric morbidity and substance use in young people aged 13-15 years: results from the Child and Adolescent Survey of Mental Health. Br J Psychiatry 2003; 182:509-517.
5. Macleod J, Oakes R, Copello A, et al. Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. Lancet 2004; 363:1579-1588. This paper summarizes the major recent literature on the subject of cannabis and mental illness.
6. Wilens TE. Attention-deficit/hyperactivity disorder and the substance use disorders: the nature of the relationship, subtypes at risk, and treatment issues. Psychiatr Clin North Am 2004; 27:283-301.
7. Barkley RA, Fischer M, Smallish L, et al. Young adult follow-up of hyperactive children: antisocial activities and drug use. J Child Psychol Psychiatry 2004; 45:195-211.
8. Riggs PD, Hall SK, Mikulich-Gilbertson SK, et al. A randomised controlled trial of pemoline for attention-deficit/hyperactivity disorder in substance-abusing adolescents. J Am Acad Child Adolesc Psychiatry 2004; 43:420-429.
9. King SM, Iacono WG, McGue M. Childhood externalising and internalising psychopathology in the prediction of early substance use. Addiction 2004; 99:1548-1559.
10. Wilens TE, Faraone SV, Biederman J, et al. Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Paediatrics 2003; 111:179-185.
11. Goodwin RD, Fergusson DM, Horwood LJ. Association between anxiety disorders and substance use disorders among young persons: results of a 21-year longitudinal study. J Psychiatr Res 2004; 38:295-304.
12. Valentiner DP, Mounts NS, Deacon DJ. Panic attacks, depression and anxiety symptoms, and substance use behaviors, during late adolescence. Anxiety Disord 2004; 18:573-585.
13. Ilomaki R, Hakko H, Timonen M, et al. Temporal relationship between the age of onset of phobic disorders and development of substance dependence in adolescent psychiatric patients. Drug Alcohol Depend 2004; 75:327-330.
14. Sung M, Erkanli A, Angold A, et al. Effects of age at first substance use and psychiatric comorbidity on the development of substance use disorders. Drug Alcohol Depend 2004; 75:287-299. This study examines the effects of age at first substance use and history of psychiatric disorders on the development of substance use disorders. The findings indicate that early use is a major predictor of later substance use disorder, even in the absence of associated psychiatric disorder.
15. Helstrom A, Bryan A, Hutchison KE, et al. Tobacco and alcohol use as an explanation for the association between externalising behavior and illicit drug use among delinquent adolescents. Prev Sci 2004; 5:267-277.
16. John U, Meyer C, Rumpf H-J, et al. Smoking, nicotine dependence and psychiatric comorbidity: a population-based study including smoking cessation after three years. Drug Alcohol Depend 2004; 76:287-295.
17. Myers MG, MacPherson L. Smoking cessation efforts among substance abusing adolescents. Drug Alcohol Depend 2004; 73:209-213.
18. Rowe CL, Liddle HA, Greenbaum PE, et al. Impact of psychiatric comorbidity on treatment of adolescent drug abusers. J Subst Abuse Treat 2004; 26:129-140. One of the first studies to demonstrate the impact of comorbidity on response to treatment in adolescents.
19. White AM, Jordan JD, Schroeder KM, et al. Predictors of relapse during treatment and treatment completion among marijuana-dependent adolescents in an intensive outpatient substance abuse program. Subst Abus 2004; 25:53-59.
20. Cornelius JR, Maisto SA, Martin CS, et al. Major depression associated with earlier alcohol relapse in treated teens with AUD. Addict Behav 2004; 29:1035-1038.
21. Jaycox LH, Morral AR, Juvonen J. Mental health and medical problems and service use among adolescent substance users. J Am Acad Child Adolesc Psychiatry 2003; 42:701-709.
22. Kelly TM, Cornelius JR, Clark DB. Psychiatric disorders and attempted suicide among adolescents with substance use disorders. Drug Alcohol Depend 2004; 73:87-97.
23. Lingford-Hughes AR, Welch S, Nutt DJ. Evidence-based guidelines for the pharmacological management of substance misuse, addiction and comorbidity: recommendations from the British Association for Psychopharmacology. J Psychopharmacol 2004; 18:293-335. This is the most comprehensive review of the pharmacological evidence base to date.
24. Green AI, Tohen MF, Hamer RM, et al. First episode schizophrenia-related psychosis and substance use disorders: acute response to olanzapine and haloperidol. Schizophr Res; 66:125-135.
25. Waldron HB, Kaminer Y. On the learning curve: the emerging evidence supporting cognitive-behavioral therapies for adolescent substance abuse. Addiction 2004; 99 (Suppl 2):93-105. This paper summarizes the evidence on CBT in adolescent substance misuse. It indicates that group therapy may be effective.
26. Kaminer Y, Burleson JA. Psychotherapies for adolescent substance abusers: 15-month follow-up. Am J Addict 1999; 8:114-119.
27. Liddle HA, Dakof GA, Diamond GS, et al. Multidimensional family therapy for adolescent substance abuse: results of a randomised clinical trial. Am J Drug Alcohol Abuse 2001; 27:651-687.
28. Waldron HB, Slesnick N, Brody JL, et al. Treatment outcomes for adolescent substance abuse at 4- and 7-month assessments. J Consult Clin Psychol 2001; 69:802-813.
29. Dennis ML, Godley SH, Diamond G, et al. The Cannabis Youth Treatment (CYT) study: main findings from two randomised trials. J Subst Abuse Treat 2004; 27:197-213.
30. Wu P, Hoven CW, Fuller CJ. Factors associated with adolescents receiving drug treatment: findings from the National Household Survey on drug abuse. J Behav Health Serv Res 2003; 30:190-201.
31. Palomo T, Kostrzewa RM, Beninger RJ, et al. Gene-environment interplay in alcoholism and other substance abuse disorders: expressions of heritability and factors influencing vulnerabilities. Neurotox Res 2004; 6:343-361.
32. Kirisci L, Tarter RE, Vanyukov M, et al. Relation between cognitive distortions and neurobehavior disinhibition on the development of substance use during adolescence and substance use disorder by young adulthood: a prospective study. Drug Alcohol Depend 2004; 76:125-133.
33. Silberg J, Rutter M, D'Onofrio B, et al. Genetic and environmental risk factors in adolescent substance use. J Child Psychol Psychiatry 2003; 44:664-676.